169 related articles for article (PubMed ID: 24862891)
1. Physician and patient willingness to pay for electronic cardiovascular disease management.
Deal K; Keshavjee K; Troyan S; Kyba R; Holbrook AM
Int J Med Inform; 2014 Jul; 83(7):517-28. PubMed ID: 24862891
[TBL] [Abstract][Full Text] [Related]
2. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
Deal K; Marshall D; Dabrowski D; Charter A; Bukoski M; Moayyedi P
Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
5. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trial.
Whitty JA; Stewart S; Carrington MJ; Calderone A; Marwick T; Horowitz JD; Krum H; Davidson PM; Macdonald PS; Reid C; Scuffham PA
PLoS One; 2013; 8(3):e58347. PubMed ID: 23505491
[TBL] [Abstract][Full Text] [Related]
6. Measuring Preferences for a Diabetes Pay-for-Performance for Patient (P4P4P) Program using a Discrete Choice Experiment.
Chen TT; Tung TH; Hsueh YS; Tsai MH; Liang HM; Li KL; Chung KP; Tang CH
Value Health; 2015 Jul; 18(5):578-86. PubMed ID: 26297085
[TBL] [Abstract][Full Text] [Related]
7. Patient preferences for a polypill for the prevention of cardiovascular diseases.
Laba TL; Howard K; Rose J; Peiris D; Redfern J; Usherwood T; Cass A; Patel A; Jan S
Ann Pharmacother; 2015 May; 49(5):528-39. PubMed ID: 25680761
[TBL] [Abstract][Full Text] [Related]
8. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer.
Howard K; Salkeld G
Value Health; 2009; 12(2):354-63. PubMed ID: 18657102
[TBL] [Abstract][Full Text] [Related]
9. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
[TBL] [Abstract][Full Text] [Related]
10. Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway.
Glenngård AH; Hjelmgren J; Thomsen PH; Tvedten T
Nord J Psychiatry; 2013 Oct; 67(5):351-9. PubMed ID: 23245636
[TBL] [Abstract][Full Text] [Related]
11. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
[TBL] [Abstract][Full Text] [Related]
12. A Discrete Choice Experiment to Elicit Patient Willingness to Pay for Attributes of Treatment-Induced Symptom Relief in Comorbid. Insomnia.
Roy AN; Madhavan SS; Lloyd A
Manag Care; 2015 Apr; 24(4):42-8. PubMed ID: 26489177
[TBL] [Abstract][Full Text] [Related]
13. Physician use of IT: results from the Deloitte Research Survey.
Miller RH; Hillman JM; Given RS
J Healthc Inf Manag; 2004; 18(1):72-80. PubMed ID: 14971083
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay for a cardiovascular prevention program in highly educated adults: a randomized controlled trial.
Jacobs N; Drost R; Ament A; Evers S; Claes N
Int J Technol Assess Health Care; 2011 Oct; 27(4):283-9. PubMed ID: 22004768
[TBL] [Abstract][Full Text] [Related]
15. Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].
Moro D; Schlander M; Telser H; Sola-Morales O; Clark MD; Olaye A; Camp C; Jain M; Butt T; Bakshi S
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):581-598. PubMed ID: 34877915
[TBL] [Abstract][Full Text] [Related]
16. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences for management of high blood pressure in the UK: a discrete choice experiment.
Fletcher B; Hinton L; McManus R; Rivero-Arias O
Br J Gen Pract; 2019 Sep; 69(686):e629-e637. PubMed ID: 31405832
[TBL] [Abstract][Full Text] [Related]
18. Willingness to accept versus willingness to pay in a discrete choice experiment.
Grutters JP; Kessels AG; Dirksen CD; van Helvoort-Postulart D; Anteunis LJ; Joore MA
Value Health; 2008 Dec; 11(7):1110-9. PubMed ID: 18489505
[TBL] [Abstract][Full Text] [Related]
19. Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.
Herbild L; Bech M; Gyrd-Hansen D
Value Health; 2009 Jun; 12(4):560-7. PubMed ID: 18980634
[TBL] [Abstract][Full Text] [Related]
20. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
